First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti–IL-20 Monoclonal Antibody in Patients with Psoriasis

Clinical Pharmacokinetics of the Anti-Interleukin-20 Monoclonal Antibody NNC0109-0012 in Healthy Volunteers and Patients with Psoriasis or Rheumatoid Arthritis

(2015) Mia Sandberg Lundblad et al.   ADVANCES IN THERAPY

Potential Synergy between SNP and CpG-A or IL-1β in Regulating Transcriptional Activity of IL-20 Promoter

(2013) Lanqi Wang et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis

(2012) J. Leman et al.   BRITISH JOURNAL OF DERMATOLOGY

Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24

(2012) F. Wang et al.   BRITISH JOURNAL OF DERMATOLOGY

Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury

(2012) S.R. Hofmann et al.   CLINICAL IMMUNOLOGY

Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A?systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis

(2011) Amanda Robinson et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature

(2010) E Puzenat et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model

(2009) K. Stenderup et al.   BRITISH JOURNAL OF DERMATOLOGY

IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytesviaincreased IL-22 receptor expression

(2009) Mikiko Tohyama et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not

(2009) Kerstin Wolk et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Trends in incidence of adult-onset psoriasis over three decades: A population-based study

(2009) Murat Icen et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes

(2008) Kerstin Wolk et al.   JOURNAL OF LEUKOCYTE BIOLOGY

The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004

(2008) Shanu Kohli Kurd et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY